This week was full of interesting developments — catch up with some weekend reading from @crossborderbio:
- Great new VC blog – really smart stuff from Peter Carrescia at http://techdisruptions.com/ #vc #blog 19 hours ago
- WSJ VC Blog sums up #JPM10 http://viigo.im/25Ba 23 hours ago
- Friday Science Review: January 15, 2010 – A little sunflower power to brighten up a quiet week… http://ow.ly/16lvd5 23 hours ago
- RT @SternIR: gr8 JPM ths year, investors looking 4 new ideas; most active BD scene evr. Prediction that ths will come 2 fruition in 1H10 1 day ago
- RT @FierceBiotech: Georgia officials map out Atlanta R&D complex, hope to create 7,000 biotech jobs. http://is.gd/6jGak 1 day ago
- Told you it wasn’t over. Obama mounts fight against 12 years of data exclusivity http://viigo.im/25qZ 1 day ago
- @dgmacarthur @genomicslawyer that Motely Fool piece on sequencing costs is by @BiologyFool typical smart stuff from a fellow Bishop lab alum 1 day ago
- via @genomicslawyer (from PGx Reporter) @Navigenics gave up DTC marketing to get NY clinical laboratory license http://bit.ly/5wbdVB 1 day ago
- RT @onelazyeye: How Google Ranks Tweets http://bit.ly/6qHDfg 1 day ago
- RT @WSJHealthBlog: Turns Out, Pfizer Was Also Questioned in EU On Generic Deals http://bit.ly/4UPyV5 1 day ago
- New Post: Biotech Trends Update Commercialization by Foundations: JDRF, J&J and DexCom Collaborate on Artificial P… http://ow.ly/16l4dG 1 day ago
- Expect more scrutiny http://ow.ly/16kw8i RT @FiercePharma: FTC: Record count on pay-for-delay deals. http://bit.ly/8gzmW2 1 day ago
- RT @matthewherper: What I wrote about FTC and pay-to-delay deals in 2006: http://bit.ly/8Rb2Eh Interesting Leibowitz then=Leibowitz now. 2 days ago
- RT @SternIR: Check out Boston Globe article on mood for biotech investing at #JPM10: $ALKS and Stern IR both weigh in! http://bit.ly/4ox3ft 2 days ago
- Ontario Institute for Cancer Research Appoints 2 Frmr Industry Execs as Chief Commercial Officer & Deputy Director http://viigo.im/24fT 2 days ago
- The Health Technology Exchange (HTX), invests $1.7 million in seven emerging medical tech companies http://viigo.im/24ft 2 days ago
- RT @davidakin: #NRU repairs could B further delayed. AECL says still hoping 2 return #isotope producer 2 action in March but could B April. 2 days ago
- @scotthensley Also couldn’t extricate for the FTC briefing @matthewherper ? Don’t see a webcast, but here’s the release http://bit.ly/7BFsYs 2 days ago
-
- RT @dgmacarthur: Dramatic news from @bioitworld: Visigen founder sues Life Tech for breach of contract and fraud: http://bit.ly/8PPzDH
- RT @mrcglobal: AFRICA: Task-shifting, new technology crucial to ending mother-to-child transmission http://bit.ly/54IN6M
- RT @FierceBiotech: Pharmaxis buys Topigen in all-stock deal. http://is.gd/68fLQ
- Monsanto to allow re-planting,generics,unrestricted stacking after Roundup ready soybean patents expire http://bit.ly/60oX8N via @iambiotech
- @fodden Best jobs – I moved from #4 Biologist to #80 Attorney (right under PR exec). No regrets! http://bit.ly/8qSU64 #slawca in reply to fodden
- RT @genomicslawyer: Personalized genomic information: preparing for the future of genetic medicine: http://bit.ly/5o52C5 (HT @nutrigenomics)
- Trillium Therapeutics and Biogen Idec $BIIB enter global license agreement. Up-front, milestone & royalty not disclosed http://bit.ly/5I7l2D
- Cytopia shareholders vote in favour of YM Biosciences acquisition final Arrangement order expected Jan 18 http://bit.ly/5uPlZS
- Just the beginning http://ow.ly/16gUQA RT @mikesgene: Three Ways Babies are Born to Specifications… http://ga.newsi.us/?x=ls
- RT @PharmProEditor: MedGenesis, Biovail to Work Together on a Treatment for Parkinson’s Disease http://bit.ly/6fLYdh
- RT @PharmProEditor: Microbix And Therapure Biopharma Form Partnership To Expand Water-Based Supplies To #Pharma http://bit.ly/7TPZWY
- New FDA Basics site has faqs, video interviews, well-organized links to further info. http://bit.ly/5OA9B2
- More scrutiny .. RT @PharmProEditor: European Union to Check Drug Makers’ Deals With Generic Rivals http://bit.ly/8pzLIo
- New project will create reference #genome for the sunflower family of crops http://bit.ly/79eZbp
- RT @JohnCFierce: What a difference a year makes. Bearish a year ago. BULLISH now. #JPM10
- RT @FierceBiotech: RT @BioPharmaToday: Teva #JPM10 biosimilars will be 9% of sales by 2015
- Nice write up for Cogniciti in the Globe today http://bit.ly/8ZjOJA Congrats @MaRSDD and Baycrest!
- BIA and Chapter 11 filings by Haemacure Corporation $HAE Friday. Angiotech to provide up to $1m financing. http://bit.ly/52JG5h
- RT @lisamjarvis: Biotechs raised $55.7b in ’09, up 85% over ’08, Burrill says: http://bit.ly/4IXb7v #JPM10
- RT @PharmProEditor: Patheon Inc. Signs Two 5-year Manufacturing Agreement Renewals with Sanofi-Aventis http://bit.ly/72Iz6K
- RT @JohnCFierce: Licensing deals soared 85% last year,says Burrill.To me,that shows just how resilient biotech companies can be…Kudos
- YM BioSciences collab with U Toronto to develop “novel radionuclide-conjugated antibody molecule” http://viigo.im/22×6
- RT @FDAcdrhIndustry: #FDA Awards Contract to Harvard Pilgrim to Develop Pilot for Safety Monitoring System http://bit.ly/7LZ24J
- via @genomicslawyer: It’s the phenotype,stupid! Gr8 post by @lindaavey on #omics probs from “gallimaufry of phenotypes” http://bit.ly/7gHIWc
